Table 1—

Screening characteristics

n17
Sex (M/F)14/3
Ethnicity (Caucasian/African-American)9/8
Age (years)56 ± 3 (37–70)
Duration of type 2 diabetes (years)7 ± (1–16)
Weight (kg)102.3 ± 5.2 (69.5–151.5)
Height (cm)175 ± 2 (157–196)
BMI (kg/m2)33.1 ± 1.4 (25.1–44.9)
HbA1c (%)8.8 ± 0.4 (6.1–11.8)
Microalbumin (μg/ml)83 ± 17 (22–311)*
Oral antidiabetic agent/diet (yes/no)16/1
 Sulfonylureas9
 Biguanides3
 Biguanides + sulfonylureas4
ACE inhibitor (yes/no)8/9
 ACE-16
 ARB1
 ARB or ACE-1 + β-blocker1
Systolic blood pressure (mmHg)151 ± 4 (111–177)*
Diastolic blood pressure (mmHg)85 ± 2 (73–94)*
Smoke (yes/no)3/14
Lipid medications (yes/no)4/13
 Gemfibrazole1
 Gemfibrazole + niacin1
 HMG-CoA reductase inhibitors2
  • Data are means ± SE (range) or n.

  • *

    * To meet recruitment goals, microalbumin and blood pressure exclusion criteria were broadened slightly. HMG, hydroxymethylglutaryl.